nach oben

Digestive Diseases and Sciences

Erschienen in:

11.05.2018 | Correspondence

Gammadelta T Cells: Unconventional T Cells Involved in IBD Pathogenesis

verfasst von: Ignacio Catalan-Serra, Juan Carlos Andreu-Ballester, Torunn Bruland, Arne Kristian Sandvik

Erschienen in: Digestive Diseases and Sciences | Ausgabe 7/2018

Einloggen, um Zugang zu erhalten

Excerpt

To the Editors, …

Giuffrida P, Corazza GR, Di Sabatino A. Old and new lymphocyte players in inflammatory bowel disease. Dig Dis Sci. 2018;63:277–288.CrossRefPubMed

Goldberg R, Prescott N, Lord GM, MacDonald TT, Powell N. The unusual suspects–innate lymphoid cells as novel therapeutic targets in IBD. Nat Rev Gastroenterol Hepatol. 2015;12:271–283.CrossRefPubMed

Treiner E. Mucosal-associated invariant T cells in inflammatory bowel diseases: bystanders, defenders, or offenders? Front Immunol. 2015;6:27.PubMedPubMedCentral

Andreu-Ballester JC, Amigó-García V, Catalán-Serra I, et al. Deficit of gammadelta T lymphocytes in the peripheral blood of patients with Crohn’s disease. Dig Dis Sci. 2011;56:2613–2622.CrossRefPubMed

Catalan Serra I, Bruland T, Sandvik A, et al. Gammadelta T cells deficiency in the peripheral blood of patients with Crohn’s disease: inverse correlation with clinical and endoscopical activity. Gastroenterology. 2017;5(Suppl1):S616.CrossRef

Mann ER, McCarthy NE, Peake ST, et al. Skin- and gut-homing molecules on human circulating γδT cells and their dysregulation in inflammatory bowel disease. Clin Exp Immunol. 2012;170:122–130.CrossRefPubMedPubMedCentral

McCarthy NE, Hedin CR, Sanders TJ, et al. Azathioprine therapy selectively ablates human Vδ2⁺ T cells in Crohn’s disease. J Clin Invest. 2015;125(3215–25):41.

Kadivar M, Petersson J, Svensson L, Marsal J. CD8αβ+ γδT cells: a novel T cell subset with a potential role in inflammatory bowel disease. J Immunol. 2016;197:4584–4592.CrossRefPubMed

Deusch K, Lüling F, Reich K, Classen M, Wagner H, Pfeffer K. A major fraction of human intraepithelial lymphocytes simultaneously expresses the gamma/delta T cell receptor, the CD8 accessory molecule and preferentially uses the V delta 1 gene segment. Eur J Immunol. 1991;21:1053–1059.CrossRefPubMed

10.

Chien YH, Meyer C, Bonneville M. γδT cells: first line of defense and beyond. Annu Rev Immunol. 2014;32:121–155.CrossRefPubMed

11.

Catalan-Serra I, Sandvik AK, Bruland T, Andreu-Ballester JC. Gammadelta T cells in Crohn’s disease: a new player in the disease pathogenesis? J Crohns Colitis. 2017. https://doi.org/10.1093/ecco-jcc/jjx039.PubMedCrossRef

12.

Inagaki-Ohara K, Chinen T, Matsuzaki G, et al. Mucosal T cells bearing TCR gammadelta play a protective role in intestinal inflammation. J Immunol. 2004;173:1390–1398.CrossRefPubMed

13.

Hoffmann JC, Pawlowski NN, Grollich K, Loddenkemper C, Zeitz M, Kühl AA. Gammadelta T lymphocytes: a new type of regulatory T cells suppressing murine 2,4,6-trinitrobenzene sulphonic acid [TNBS]-induced colitis. Int J Colorectal Dis. 2008;23:909–920.CrossRefPubMed

14.

Andreu-Ballester JC, Garcia-Ballesteros C, Amigo V, et al. Microsporidia and its relation to Crohn’s disease. A retrospective study. PLoS One. 2013;8:e62107.CrossRefPubMedPubMedCentral

15.

Dart RJ, Vantourout P, Laing A, et al. DOP075 Colonic gamma delta T-cells respond innately to NKG2D ligands and are grossly dysregulated in active inflammatory bowel disease. J Crohns Colitis. 2018;12(Suppl. 1):S081. https://doi.org/10.1093/ecco-jcc/jjx180.112.CrossRef

16.

Li J, Ueno A, Iacucci M, et al. Crossover subsets of CD4(+) T lymphocytes in the intestinal lamina propria of patients with Crohn’s disease and ulcerative colitis. Dig Dis Sci. 2017;62:2357–2368.CrossRefPubMed

17.

Alfen JS, Larghi P, Facciotti F, et al. Intestinal IFN-γ-producing type 1 regulatory T cells coexpress CCR5 and programmed cell death protein 1 and downregulate IL-10 in the inflamed guts of patients with inflammatory bowel disease. J Allergy Clin Immunol. 2018 Jan 31. (Epub ahead of print).

18.

Paroni M, Magarotto A, Tartari S, et al. Uncontrolled IL-17 production by intraepithelial lymphocytes in a case of non-IPEX autoimmune enteropathy. Clin Transl Gastroenterol. 2016;7:e182.CrossRefPubMedPubMedCentral

19.

Backert I, Koralov SB, Wirtz S, et al. STAT3 activation in Th17 and Th22 cells controls IL-22-mediated epithelial host defense during infectious colitis. J Immunol. 2014;193:3779–3791.CrossRefPubMed

Titel: Gammadelta T Cells: Unconventional T Cells Involved in IBD Pathogenesis
verfasst von: Ignacio Catalan-Serra
Juan Carlos Andreu-Ballester
Torunn Bruland
Arne Kristian Sandvik
Publikationsdatum: 11.05.2018
Verlag: Springer US
Erschienen in: Digestive Diseases and Sciences / Ausgabe 7/2018
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI: https://doi.org/10.1007/s10620-018-5059-7

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Gammadelta T Cells: Unconventional T Cells Involved in IBD Pathogenesis

Excerpt

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2018

Advanced Age Does Not Negatively Impact Health-Related Quality of Life in Inflammatory Bowel Disease

Competence, Confidence, and Certification: Observations from Both Sides of the Aisle

Progressive Epigastric Pain with Abnormal Liver Tests in a Patient with Crohn’s Disease: Don’t DILI Dally

Antenatal Management for Women with Inflammatory Bowel Disease: Experience from Our ‘IBD MOM’ Clinic

Systemic Inflammatory Responses in Ulcerative Colitis Patients and Clostridium difficile Infection

The Impact of Tumor Differentiation on the Prognosis of HBV-Associated Solitary Hepatocellular Carcinoma Following Hepatectomy: A Propensity Score Matching Analysis

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin